Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

9 Meters Biopharma Inc (NASDAQ: NMTR)

 
NMTR Technical Analysis
4
As on 9th Jun 2023 NMTR STOCK Price closed @ 0.72 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.68 & Sell for SHORT-TERM with Stoploss of 0.77 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NMTRSTOCK Price

Open 0.78 Change Price %
High 0.78 1 Day -0.06 -7.69
Low 0.71 1 Week -0.08 -10.00
Close 0.72 1 Month -0.32 -30.77
Volume 88300 1 Year -0.25 -25.77
52 Week High 2.92 | 52 Week Low 0.18
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
NMTR
Daily Charts		 NMTR
Intraday Charts		 Whats New @
Bazaartrend		 NMTR
Free Analysis
 
NMTR Important Levels Intraday
RESISTANCE0.85
RESISTANCE0.81
RESISTANCE0.78
RESISTANCE0.76
SUPPORT0.68
SUPPORT0.66
SUPPORT0.63
SUPPORT0.59
 
NMTR Forecast May 2024
Share
4th UP Forecast1.41
3rd UP Forecast1.19
2nd UP Forecast1.05
1st UP Forecast0.92
1st DOWN Forecast0.52
2nd DOWN Forecast0.39
3rd DOWN Forecast0.25
4th DOWN Forecast0.03
 
NMTR Weekly Forecast
4th UP Forecast1.03
3rd UP Forecast0.93
2nd UP Forecast0.87
1st UP Forecast0.81
1st DOWN Forecast0.63
2nd DOWN Forecast0.57
3rd DOWN Forecast0.51
4th DOWN Forecast0.41
 
NMTR Forecast2024
4th UP Forecast7.54
3rd UP Forecast5.35
2nd UP Forecast4
1st UP Forecast2.65
1st DOWN Forecast-1.21
2nd DOWN Forecast-2.56
3rd DOWN Forecast-3.91
4th DOWN Forecast-6.1
 
 
NMTR Other Details
Segment EQ
Market Capital 328631360.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NMTR Address
NMTR
 
NMTR Latest News
 
Your Comments and Response on 9 Meters Biopharma Inc
 
NMTR Business Profile
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on patients with rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS) and celiac disease, as well as for undisclosed rare diseases and/or unmet needs. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease; and NM-002, a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist that is in Phase 2 clinical trial to treat SBS. It also develops NM-102, a small molecule peptide; NM-003, a proprietary long-acting glucagon-like peptide-2; and NM-004, a double-cleaved mesalamine with an immunomodulator for rare and/or orphan indications. 9 Meters Biopharma, Inc. has a collaboration with the Duke Clinical Research Institute to support the clinical development of NM-002. The company is headquartered in Raleigh, North Carolina. Address: 8480 Honeycutt Road, Raleigh, NC, United States, 27615
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service